Neurocarrus cover feature

Neurocarrus

Non-opioid drug treats pain without risk of addiction
$330,971 Raised
Ended April 19th
490 Investors

Since 2017 the opioid epidemic has been classified as national emergency. We're developing a non-opioid drug to treat pain without risk of addiction. So far we've shown promising results in animal trials and are fundraising to continue pre-clinical development. 

Why you may want to invest
  1. Founder has been working in space for 25+ years.

  2. Early animal trials show pain relief equal to that of opioids but lasting 3x as long.

  3. No addictive potential because drug is locally delivered and won't enter the brain. 

  4. Drug is highly innovative and first of its kind.

  5. IndieBio Accelerator Spring 2018.

  6. $10K awarded by the U.S. National Institute on Drug Abuse.

  7. Produces no doping effects and movement remains normal

Learn more about this company

Company Details

Location
Monterey, CA
Founded
2017
Employees
2

Key Team Members

Paul Blum
Co-founder/CEO

Financials

Most recent Fiscal Year

Income Statement

Revenue
$0
Cost of Goods Sold
$0
Gross Profit
$0
Taxes
$0
Net Income
-$51,923

Balance Sheet

Total Assets
$99,343
Cash
$25,593
Accounts Receivable
$0
Short Term Debt
$21,156
Long Term Debt
$100,000

Other popular startups

Get email updates for the latest investment opportunities
Email
Email